Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,908 | -2,428 | N/A | N/A | N/A |
| Depreciation Amortization | 3 | 2 | N/A | N/A | N/A |
| Other Working Capital | -939 | 181 | N/A | N/A | N/A |
| Other Operating Activity | 1,192 | 118 | 0 | 0 | 0 |
| Operating Cash Flow | $-5,652 | $-2,128 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -6 | N/A | N/A | N/A |
| Investing Cash Flow | $-16 | $-6 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 169 | N/A | N/A | N/A | N/A |
| Debt Issued | 109 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 26,302 | 2,921 | N/A | N/A | N/A |
| Other Financing Activity | -2,914 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $23,665 | $2,921 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,232 | 445 | N/A | N/A | N/A |
| End Cash Position | 19,229 | 1,232 | N/A | N/A | N/A |
| Net Cash Flow | $17,997 | $787 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,652 | -2,128 | N/A | N/A | N/A |
| Capital Expenditure | -16 | -6 | N/A | N/A | N/A |
| Free Cash Flow | -5,668 | -2,134 | 0 | 0 | 0 |